Related Experiment Video
Updated: Mar 3, 2026

Biological Preparation and Mechanical Technique for Determining Viscoelastic Properties of Zonular Fibers
Published on: December 16, 2021
Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome
Romy Franken1,2, Gisela Teixido-Tura1, Maria Brion3
1Servei de Cardiologia, Unitat de Marfan, Hospital Universitari, Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Background:
The effect of FBN1 mutation type on the severity of cardiovascular manifestations in patients with Marfan syndrome (MFS) has been reported with disparity results.
Objectives:
This study aims to determine the impact of the FBN1 mutation type on aortic diameters, aortic dilation rates and on cardiovascular events (ie, aortic dissection and cardiovascular mortality).
Methods:
MFS patients with a pathogenic FBN1 mutation followed at two specialised units were included. FBN1 mutations were classified as being dominant negative (DN; incorporation of non-mutated and mutated fibrillin-1 in the extracellular matrix) or having haploinsufficiency (HI; only incorporation of non-mutated fibrillin-1, thus a decreased amount of fibrillin-1 protein). Aortic diameters and the aortic dilation rate at the level of the aortic root, ascending aorta, arch, descending thoracic aorta and abdominal aorta by echocardiography and clinical endpoints comprising dissection and death were compared between HI and DN patients.
Results:
Two hundred and ninety patients with MFS were included: 113 (39%) with an HI-FBN1 mutation and 177 (61%) with a DN-FBN1. At baseline, patients with HI-FBN1 had a larger aortic root diameter than patients with DN-FBN1 (HI: 39.3±7.2 mm vs DN: 37.3±6.8 mm, p=0.022), with no differences in age or body surface area. After a mean follow-up of 4.9±2.0 years, aortic root and ascending dilation rates were increased in patients with HI-FBN1 (HI: 0.57±0.8 vs DN: 0.28±0.5 mm/year, p=0.004 and HI: 0.59±0.9 vs DN: 0.30±0.7 mm/year, p=0.032, respectively). Furthermore, patients with HI-FBN1 tended to be at increased risk for the combined endpoint of dissection and death compared with patients with DN-FBN1 (HR: 3.3, 95% CI 1.0 to 11.4, p=0.060).
Conclusions:
Patients with an HI mutation had a more severely affected aortic phenotype, with larger aortic root diameters and a more rapid dilation rate, and tended to have an increased risk of death and dissections compared with patients with a DN mutation.
Insights
Patients with haploinsufficiency (HI) FBN1 mutations in Marfan syndrome experience more severe aortic dilation and a higher risk of dissection or death compared to those with dominant negative (DN) FBN1 mutations.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Marfan Syndrome Research
Background:
- The impact of FBN1 mutation type on cardiovascular manifestations in Marfan syndrome (MFS) remains debated.
- FBN1 mutations are classified as dominant negative (DN) or haploinsufficiency (HI).
Purpose of the Study:
- To investigate the influence of FBN1 mutation type (DN vs. HI) on aortic dimensions and dilation rates.
- To assess the effect of FBN1 mutation type on cardiovascular events, including aortic dissection and mortality in MFS patients.
Main Methods:
- Compared aortic diameters and dilation rates in MFS patients with HI-FBN1 versus DN-FBN1 mutations.
- Utilized echocardiography to measure aortic dimensions and tracked clinical endpoints like dissection and death.
- Classified FBN1 mutations based on their effect on fibrillin-1 protein in the extracellular matrix.
Main Results:
- Patients with HI-FBN1 mutations exhibited larger baseline aortic root diameters compared to DN-FBN1 patients.
- A significantly faster rate of aortic root and ascending aorta dilation was observed in the HI-FBN1 group.
- The HI-FBN1 group showed a trend towards increased risk for combined aortic dissection and death events.
Conclusions:
- Haploinsufficiency (HI) FBN1 mutations are associated with a more severe aortic phenotype in Marfan syndrome.
- HI mutations lead to larger aortic diameters and accelerated dilation, increasing the risk of dissection and mortality compared to dominant negative (DN) mutations.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Intracellular Signaling Affects Focal Adhesions
Some...

